Product
Supplier
Encyclopedia
Inquiry
Home > Biochemical Engineering > Polypeptide > Cagrilintide for Sale > Peptide raw powder in vials, 99% purity white lyophilized
Peptide raw powder in vials, 99% purity white lyophilized buy - large image1
Peptide raw powder in vials, 99% purity white lyophilized buy - image1
Peptide raw powder in vials, 99% purity white lyophilized buy - image2
Peptide raw powder in vials, 99% purity white lyophilized buy - image3
Peptide raw powder in vials, 99% purity white lyophilized buy - image4
Peptide raw powder in vials, 99% purity white lyophilized buy - image5
Peptide raw powder in vials, 99% purity white lyophilized buy - image6

Peptide raw powder in vials, 99% purity white lyophilized

66 Inquiries

Unit Price:

$60/UNIT EXW

Get Latest Price
CAS No.:

1415456-99-3

Grade:

Research Grade

Content:

99%

Port:

qingdao

Packaging:

5mg;10mg;15mg;20mg;30mg;40mg;50mg;100mg;500mg

Price valid (until):

2027-01-31

Company Type:
Trader
Location:
China
Qualification:
Main Products:

Cosmetics

  • Product Details

  • Seller Information

  • History Price

  • Inquiry History

  • Description

      Product Detail  


    Company Profile
    Our company specializes in the research, development, production, and supply of research-grade synthetic peptide raw materials for life science laboratories. We have standardized production processes and a quality control system, and are supported by an experienced sales and after-sales service team. We provide customized raw material solutions based on our customers’ experimental protocols, and our business spans multiple countries and regions. We adhere to the principles of integrity and quality first, continuously monitor market trends in research materials, and flexibly adjust our supply plans. From initial consultation, order confirmation, and production scheduling to final shipment, we efficiently process every order.


    Product Details
    This product is a research-grade synthetic peptide lyophilized powder, prepared through chemical synthesis and lyophilization to ensure product stability. Each batch undergoes sampling and testing prior to shipment. The powder is fine and uniform, dissolves well in compatible solvents, and maintains consistent batch specifications, making it suitable for laboratory research projects. We support both small and bulk orders; the larger the purchase volume, the more significant the unit price advantage. Custom packaging specifications can also be negotiated to accommodate different laboratory usage habits.


    Quality Assurance
    Strict quality control is maintained throughout the entire process, from raw material selection to finished product shipment. All upstream raw materials are sourced from compliant suppliers and undergo initial inspection prior to warehousing. Production strictly adheres to standardized operating procedures; after synthesis and purification are complete, the finished product undergoes multiple tests. Products are only released for warehousing after passing all tests.


    Packaging and Logistics
    Inner packaging consists of light-protected, sealed vials, with cushioning material on the outer layer to minimize the impact of shipping impacts and temperature fluctuations. We partner with reputable international logistics providers; shipments are arranged within 1–2 business days after payment confirmation, and a tracking number is provided for real-time shipment tracking.


    Support Services
    Our sales and technical teams provide support to laboratory procurement clients and respond to inquiries within 24 hours. If you have questions regarding specification selection, storage methods, order status, or packaging requirements, please contact us; where conditions permit, we can provide custom labeling and repackaging solutions. We continuously monitor the shipping status after the goods are dispatched; if you encounter any issues upon receipt, please contact us promptly, and we will coordinate a resolution without delay.


    Storage Conditions
    Store in a cool, dry, dark, and low-temperature environment. Avoid repeated freezing and thawing. We recommend repackaging the product in portions appropriate for experimental use to minimize the risk of loss of activity.


    Important Disclaimer
    This product is intended for laboratory research only. The purchaser is responsible for ensuring that this product is used strictly within the scope permitted for laboratory research.



    Items Specifications
    Product Type Peptide
    Grade Research Grade
    Appearance White/off-white lyophilized powder
    Packaging Sealed vials
    Available Sizes 5 mg, 10 mg, 15 mg, 20 mg, 30 mg, 40 mg, 50 mg, 100 mg, 500 mg
    MOQ 1 kit (10 vials)


    Shop High Activity High Purity Lyophilized Peptide, Abundant Stock From Source Factory-Detailed Image 1 Shop High Activity High Purity Lyophilized Peptide, Abundant Stock From Source Factory-Detailed Image 2 Shop High Activity High Purity Lyophilized Peptide, Abundant Stock From Source Factory-Detailed Image 3 Shop High Activity High Purity Lyophilized Peptide, Abundant Stock From Source Factory-Detailed Image 4

    Shop High Activity High Purity Lyophilized Peptide, Abundant Stock From Source Factory-Detailed Image 5

    ECHEMI Editorial Reference

    Cagrilintide is a long-acting amylin analog and peptide-based pharmaceutical ingredient. As a pharmaceutical raw material, Cagrilintide is characterized by its peptide structure and amylin receptor activity. It is suitable for API research, analytical testing, pharmaceutical development, and related manufacturing processes.

    Basic Info
    Product Name:

    Cagrilintide

    Other Name:

    ‌Cagrilitide、Cagrilintide acetate、Caglitide、Kagliptin、Cargliptin、Cargilinitide

    CAS No.:

    1415456-99-3

    Molecular Formula:

    C194H312N54O59S2

    Molecular Weight:

    0

    EC Number:

    206-141-6

    Color/Form:

    White to off-white

    Categories:

    Polypeptide

    Research
    Class:

    Amylin receptor (AMYR) / calcitonin receptor (CTR) agonist (long-acting amylin analog)

    Status:

    Investigational — Phase 3 (REDEFINE program, CagriSema combination)

    Mechanism:

    A novel long-acting, acylated amylin (islet amyloid polypeptide, IAPP) analog consisting of 38 amino acids. Cagrilintide activates the amylin receptor (AMYR) and calcitonin receptor (CTR), reducing food intake, delaying gastric emptying, and promoting satiety. Being developed as monotherapy and in fixed-dose combination with semaglutide (CagriSema) for obesity.

    Activity note:

    Cagrilintide is a non-selective AMYR/CTR agonist. Specific EC50 values not publicly available; functional potency is comparable to native amylin at AMYR.

    Source:

    MCE: Cagrilintide (CAS 1415456-99-3); Novo Nordisk REDEFINE program.

    Clinical Development:

    NCT05249895 ; NCT05249882

    References
    PubChem:

    PubChem

    Disclaimer:

    Cagrilintide is NOT FDA-approved or EMA-approved. It is in Phase 3 clinical trials (REDEFINE program). This listing is for industrial and laboratory research use only. It is not medical advice, a clinical recommendation, or an approved therapy description. Always verify regulatory status, purity, and intended use with the supplier and applicable authorities before purchase or use.

  • Seller Information
    Business Type:

    Trader

    Main Products:

    Cosmetics

    Location:

    Room 204, Unit 1, Building 3, Liming 1st District, Choujiang Subdistrict, Wenwu City, Jinhua City, China (Zhejiang) Pilot Free Trade Zone

    Year of Establishment:

    2026

  • Weekly Price

    The chart shows the price trend of the product in the past 12 months.

  • Inquiry History
    66 Inquiries
    Country Product Purchase Quantity Date Posted
    United States

    Cagrilintide

    20 MG Sep 30, 2026
    United States

    Cagrilintide

    10 MG Sep 23, 2026
    United States

    cagrilintide

    25 KG Sep 23, 2026
    Germany

    CAGRILINTIDE

    50 MG Sep 21, 2026
    United States

    Cagrilintide

    25 MG Aug 31, 2026
    Australia

    Cagrilintide

    1 G Aug 25, 2026
    Australia

    Cagrilintide

    20 MG Aug 17, 2026
    United States

    Retatrutid3

    10 MT Aug 4, 2026
    United States

    Cagrlintide

    1 MT Jul 31, 2026
    United Kingdom

    Cagrilintide

    10 MG Jul 31, 2026
    United States

    Retatrutide

    20 MT Jul 25, 2026
    United Kingdom

    cagrilintrude

    20 MG Jul 21, 2026
    United States

    Cagrilintide

    1 KG Jul 17, 2026
    United States

    Cagrilintide

    10 MG Jul 13, 2026
    Peru

    Cagrilintide 20MG vial

    10 PCS Jul 10, 2026
    United States

    Cagrilintide

    30 MG May 26, 2026
    France

    Cagrilintide

    10 MG May 22, 2026
    New Zealand

    Cagrilintide

    10 MG May 19, 2026
    United States

    Cagrilintide

    1 G May 18, 2026
    United States

    Cagrilintide

    20 MG May 8, 2026
    Post an enquiry for this product
pic ×

Scan the QR Code to Share

All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.

According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.

The information shown above is provided by the enterprise itself, and the authenticity, accuracy and legitimacy of the content are the responsibility of the publishing company. ECHEMI does not bear any guarantee responsibility for this. Please be aware that risks in internet transactions objectively exist.

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.